Evolent Health, Inc. Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims
Evolent Health, Inc. (EVH) reported Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims of $763.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 · last filed 2026-08-06
- Evolent Health, Inc. liability for unpaid claims and claims adjustment expense, incurred claims for the quarter ending 2026-06-30 was $461.52M, a 115.41% increase year-over-year.
- Evolent Health, Inc. liability for unpaid claims and claims adjustment expense, incurred claims for the quarter ending 2026-03-31 was $301.78M, a 46.50% increase year-over-year.
- Evolent Health, Inc. liability for unpaid claims and claims adjustment expense, incurred claims for the quarter ending 2025-12-31 was $243.16M, a 37.94% decline year-over-year.
- Evolent Health, Inc. liability for unpaid claims and claims adjustment expense, incurred claims for the quarter ending 2025-09-30 was $243.91M, a 32.25% decline year-over-year.
- Evolent Health, Inc. liability for unpaid claims and claims adjustment expense, incurred claims for fiscal 2025 was $907.30M, a 38.82% decline from fiscal 2024.
- Evolent Health, Inc. liability for unpaid claims and claims adjustment expense, incurred claims for fiscal 2024 was $1.48B, a 66.42% increase from fiscal 2023.
- Evolent Health, Inc. liability for unpaid claims and claims adjustment expense, incurred claims for fiscal 2023 was $891.09M, a 49.95% increase from fiscal 2022.
- Evolent Health, Inc. liability for unpaid claims and claims adjustment expense, incurred claims for fiscal 2022 was $594.25M, a 27.82% increase from fiscal 2021.
| Period end | Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 3 month | Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 6 month | Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 9 month | Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 12 month |
|---|---|---|---|---|
| 2026-06-30 | $461.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $763.30M 10-Q · filed 2026-08-06 | $1.01B derived: sum of 3 quarters · filed 2026-08-06 | $1.25B derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $301.78M 10-Q · filed 2026-05-07 | $544.93M derived: sum of 2 quarters · filed 2026-05-07 | $788.84M derived: sum of 3 quarters · filed 2026-05-07 | $1.00B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $243.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $487.06M derived: sum of 2 quarters · filed 2026-02-25 | $701.31M derived: sum of 3 quarters · filed 2026-08-06 | $907.30M 10-K · filed 2026-02-25 |
| 2025-09-30 | $243.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $458.15M derived: sum of 2 quarters · filed 2026-08-06 | $664.15M 10-Q · filed 2025-11-07 | $1.06B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $214.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $420.24M 10-Q · filed 2026-08-06 | $812.05M derived: sum of 3 quarters · filed 2026-08-06 | $1.17B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $205.99M 10-Q · filed 2026-05-07 | $597.80M derived: sum of 2 quarters · filed 2026-05-07 | $957.82M derived: sum of 3 quarters · filed 2026-05-07 | $1.33B derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $391.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $751.83M derived: sum of 2 quarters · filed 2026-02-25 | $1.12B derived: sum of 3 quarters · filed 2026-02-25 | $1.48B 10-K · filed 2026-02-25 |
| 2024-09-30 | $360.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $731.48M derived: sum of 2 quarters · filed 2025-11-07 | $1.09B 10-Q · filed 2025-11-07 | $1.39B derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $371.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $731.16M 10-Q · filed 2025-08-11 | $1.03B derived: sum of 3 quarters · filed 2025-08-11 | $1.26B derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $359.69M 10-Q · filed 2025-05-09 | $658.78M derived: sum of 2 quarters · filed 2025-05-09 | $891.80M derived: sum of 3 quarters · filed 2025-05-09 | $1.09B derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $299.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $532.10M derived: sum of 2 quarters · filed 2025-02-21 | $730.33M derived: sum of 3 quarters · filed 2025-02-21 | $891.09M 10-K · filed 2025-02-21 |
| 2023-09-30 | $233.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $431.24M derived: sum of 2 quarters · filed 2024-11-08 | $592.00M 10-Q · filed 2024-11-08 | $722.90M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $198.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $358.99M 10-Q · filed 2024-08-09 | $489.88M derived: sum of 3 quarters · filed 2024-08-09 | $683.84M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $160.76M 10-Q · filed 2024-05-10 | $291.66M derived: sum of 2 quarters · filed 2024-05-10 | $485.61M derived: sum of 3 quarters · filed 2024-05-10 | $645.83M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $130.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $324.85M derived: sum of 2 quarters · filed 2024-02-23 | $485.07M derived: sum of 3 quarters · filed 2024-02-23 | $594.25M 10-K · filed 2024-02-23 |
| 2022-09-30 | $193.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $354.17M derived: sum of 2 quarters · filed 2023-11-02 | $463.35M 10-Q · filed 2023-11-02 | $544.51M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $160.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $269.39M 10-Q · filed 2023-08-03 | $350.56M derived: sum of 3 quarters · filed 2023-08-03 | |
| 2022-03-31 | $109.17M 10-Q · filed 2023-05-04 | $190.34M derived: sum of 2 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $81.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $464.91M 10-K · filed 2023-02-24 | ||
| 2021-09-30 | $383.75M 10-Q · filed 2022-11-03 | |||
| 2019-09-30 | $111.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $195.48M derived: sum of 2 quarters · filed 2019-11-05 | $273.89M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $83.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $162.35M 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | $78.41M 10-Q · filed 2019-05-09 | |||
| 2018-09-30 | $16.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $35.42M derived: sum of 2 quarters · filed 2019-11-05 | $52.17M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $18.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $35.18M 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $16.75M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |